News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pharm Country
NanoViricides, Inc. Presents At FDA Nanotechnology Meeting
October 11, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc, (Pink Sheets: NNVC) President and Chairman, Dr. Anil Diwan, presented a talk at the U.S. Food and Drug Administration (FDA) Public Meeting on Nanotechnology in Bethesda, MD on Oct. 10.
Twitter
LinkedIn
Facebook
Email
Print
Events
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
ALS
New Wave of ALS Therapies Signals Renaissance After Incremental Regression
September 2, 2025
·
6 min read
·
Heather McKenzie
Obesity
Analysts Home In on Safety as Novo, Lilly, Amgen Highlight Weight Loss Data at ADA
June 27, 2025
·
5 min read
·
Heather McKenzie
IN PARTNERSHIP WITH PATSNAP
Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter
June 25, 2025
·
1 min read
·
BioSpace Insights
Rare diseases
FDA Conditional Pathway Not Necessary, Rare Disease Experts Say, While Applauding Intent
June 24, 2025
·
3 min read
·
Heather McKenzie